Human c-SRC kinase (CSK) overexpression makes T cells dummy.

about

Human c-SRC kinase (CSK) overexpression makes T cells dummy.

Item

http://www.wikidata.org/entity/Q48105379

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Human c-SRC kinase (CSK) overexpression makes T cells dummy.

@en

Human c-SRC kinase

@nl

type

Item

label

Human c-SRC kinase (CSK) overexpression makes T cells dummy.

@en

Human c-SRC kinase

@nl

prefLabel

Human c-SRC kinase (CSK) overexpression makes T cells dummy.

@en

Human c-SRC kinase

@nl

P1476

Human c-SRC kinase (CSK) overexpression makes T cells dummy

@en

P2093

Anne Fåne

http://www.w3.org/2001/XMLSchema#string

Gjertrud Skorstad

http://www.w3.org/2001/XMLSchema#string

Grethe-Elisabeth Stenvik

http://www.w3.org/2001/XMLSchema#string

Gunnar Kvalheim

http://www.w3.org/2001/XMLSchema#string

Lars-Egil Fallang

http://www.w3.org/2001/XMLSchema#string

Morten P Oksvold

http://www.w3.org/2001/XMLSchema#string

P2860

The protein LEM promotes CD8⁺ T cell immunity through effects on mitochondrial respiration

Action and Traction: Cytoskeletal Control of Receptor Triggering at the Immunological Synapse

Synthetic biology approaches to engineer T cells

Molecular mechanisms of T cell co-stimulation and co-inhibition

Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance

Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy

LYP inhibits T-cell activation when dissociated from CSK.

Differences in the kinetics, amplitude, and localization of ERK activation in anergy and priming revealed at the level of individual primary T cells by laser scanning cytometry.

T cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces in vivo tumor growth.

Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits.

P2888

s00262-017-2105-9

P304

525-536

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00262-017-2105-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29248956

http://www.w3.org/2001/XMLSchema#string

P921

overexpression